ni2o RapidTest
Countering Communicable Diseases with our Five-Minute Test
Worldwide Testing Challenges
COVID-19 has opened our eyes to the many communities who don’t have adequate disease detection technology. Ni2o’s RapidTest instrument will allow for a variety of diseases to be detected from samples collected via a non-invasive method, removing the need for specialized testing equipment and personnel.
While we hope to not endure something as devastating as COVID-19 in the near future, another pandemic may be inevitable. A lag in testing can overwhelm labs and hospitals, allowing a contagious disease to spread almost undetected.
Quick Point-of-Care (POC) testing is crucial for ensuring lower pathogen transmissibility. That is why ni2o is beginning development on cartridges to address common diseases such as Influenza A/B, HIV, and Hepatitis.
With 20 million daily tests needed in the United States, current state-of-the-art tests are too slow, expensive, and require trained personnel. The sheer number of cases coupled with the lag in testing can overwhelm labs and hospitals, allowing the virus to spread undetected.
The Need for Speed
Rapid testing for antibodies and viral load, detecting exposure, and assessing risk within minutes will provide benefits throughout the healthcare ecosystem.
ni2o RapidTest provides rapid and scalable screenings of populations to understand immunity and enable timely, sustainable national and global responses.
Robust Testing System
Currently, many communities are flying blind in their pandemic response. The World Health Organization (WHO) reports with the rise in global cases, COVID-19 continues to have a high transmission rate and a long incubation period, allowing it to spread quickly, often without symptoms.
With 20 million daily tests needed in the United States, current state-of-the-art tests are too slow, expensive, and require trained personnel. The sheer number of cases coupled with the lag in testing can overwhelm labs and hospitals, allowing the virus to spread undetected.
Personnel
Tests can be performed without trained professionals, reducing exposure
Speed
Test results are available within 5 minutes or less
Samples
Non-invasive sample collection using saliva
Setting
Tests can be done at home, at a doctor’s office, or at schools and workplaces
Integration
Device can communicate results via USB, allowing rich integration
Flatten the Curve
Our test quickly produces results with high accuracy and detects exposure in asymptomatic carriers, patients who are visibly ill, and those who were infected with COVID-19 in the past. Easy and affordable in-home, school, and workplace testing allows for informed, effective self-isolation and quarantine protocols.